Pedro Pesini
Corporate Officer/Principal presso Araclon Biotech SL
Profilo
Pedro Pesini is currently the Head-Laboratory at Araclon Biotech SL since 2007.
Prior to this, he held the position of Principal at Karolinska Institutet, the University of Bristol, and the University of Santiago de Compostela.
Posizioni attive di Pedro Pesini
| Società | Posizione | Inizio |
|---|---|---|
Araclon Biotech SL
 Araclon Biotech SL Miscellaneous Commercial ServicesCommercial Services Araclon Biotech SL researches and develops therapies and diagnostic methods for Alzheimer’s disease. Its research areas include early diagnosis of Alzheimer’s disease; therapy for Alzheimer’s disease; development of a predictive test for the Alzheimer’s disease in asymptomatic individuals; and development of therapy for Parkinson’s disease. The company was founded on January 27, 2004 and is headquartered in Zaragoza, Spain. | Corporate Officer/Principal | 09/04/2010 |
Precedenti posizioni note di Pedro Pesini
| Società | Posizione | Fine |
|---|---|---|
| University of Bristol | Corporate Officer/Principal | - |
| Karolinska Institutet | Corporate Officer/Principal | - |
| University of Santiago de Compostela | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Araclon Biotech SL
Araclon Biotech SL Miscellaneous Commercial ServicesCommercial Services Araclon Biotech SL researches and develops therapies and diagnostic methods for Alzheimer’s disease. Its research areas include early diagnosis of Alzheimer’s disease; therapy for Alzheimer’s disease; development of a predictive test for the Alzheimer’s disease in asymptomatic individuals; and development of therapy for Parkinson’s disease. The company was founded on January 27, 2004 and is headquartered in Zaragoza, Spain. | Commercial Services |
- Borsa valori
- Insiders
- Pedro Pesini
